{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:28:40Z","timestamp":1761708520955,"version":"3.35.0"},"reference-count":120,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T00:00:00Z","timestamp":1274140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Orthotopic liver transplantation (OLT) is currently incorporated into the treatment regimens for specific nonhepatocellular malignancies. For patients suffering from early-stage, unresectable hilar cholangiocarcinoma (CCA), OLT preceded by neoadjuvant radiotherapy has the potential to readily achieve a tumor-free margin, accomplish a radical resection, and treat underlying primary sclerosing cholangitis when present. In highly selected stage I and II patients with CCA, the 5-year survival rate is 80%. As additional data are accrued, OLT with neoadjuvant chemoradiation may become a viable alternative to resection for patients with localized, node-negative hilar CCA. Hepatic involvement from neuroendocrine tumors can be treated with OLT when metastases are unresectable or for palliation of medically uncontrollable symptoms. Five-year survival rates as high as 90% have been reported, and the Ki67 labeling index can be used to predict outcomes after OLT. Hepatic epithelioid hemangioendothelioma is a rare tumor of vascular origin. The data from single-institution series are limited, but compiled reviews have reported 1- and 10-year survival rates of 96% and 72%, respectively. Hepatoblastoma is the most common primary hepatic malignancy in children. There exist subtle differences in the timing of chemotherapy between US and European centers; however, the long-term survival rate after transplantation ranges from 66% to 77%. Fibrolamellar hepatocellular carcinoma is a distinct liver malignancy best treated by surgical resection. However, there is an increasing amount of data supporting OLT when resection is contraindicated. In the treatment of either primary or metastatic hepatic sarcomas, unacceptable survival and recurrence rates currently prohibit the use of OLT. Liver Transpl 16:930-942, 2010. \u00a9 2010 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.22106","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T23:21:46Z","timestamp":1274224906000},"page":"930-942","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature"],"prefix":"10.1097","volume":"16","author":[{"given":"Eric J.","family":"Grossman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Millis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20250203","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000658-198510000-00001","article-title":"Role of liver transplantation in cancer therapy.","volume":"202","author":"Iwatsuki","year":"1985","journal-title":"Ann Surg"},{"key":"R2-2-20250203","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SLA.0b013e318148c704","article-title":"Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.","volume":"246","author":"Duffy","year":"2007","journal-title":"Ann Surg"},{"key":"R3-2-20250203","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers.","volume":"341","author":"de Groen","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-2-20250203","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma.","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"R5-2-20250203","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820801992542","article-title":"Surgery for cholangiocarcinoma: the role of liver transplantation.","volume":"10","author":"Rosen","year":"2008","journal-title":"HPB (Oxford)"},{"key":"R6-2-20250203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1634\/theoncologist.9-1-43","article-title":"Diagnosis and treatment of cholangiocarcinoma.","volume":"9","author":"Anderson","year":"2004","journal-title":"Oncologist"},{"key":"R7-2-20250203","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-2036.2006.02900.x","article-title":"Review article: the modern diagnosis and therapy of cholangiocarcinoma.","volume":"23","author":"Malhi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-2-20250203","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/1098-2388(200009)19:2<156::AID-SSU8>3.0.CO;2-#","article-title":"Cholangiocarcinoma of the extrahepatic bile ducts.","volume":"19","author":"Jarnagin","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"R9-2-20250203","first-page":"248","article-title":"The role of liver transplantation for hilar cholangiocarcinoma.","volume":"6","author":"Pandey","year":"2007","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R10-2-20250203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000658-199101000-00004","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis.","volume":"213","author":"Rosen","year":"1991","journal-title":"Ann Surg"},{"key":"R11-2-20250203","first-page":"6465","article-title":"Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.","volume":"13","author":"Stutes","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R12-2-20250203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1478-3231.2007.01624.x","article-title":"Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.","volume":"28","author":"Sandhu","year":"2008","journal-title":"Liver Int"},{"key":"R13-2-20250203","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.1139","article-title":"Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.","volume":"197","author":"Tannapfel","year":"2002","journal-title":"J Pathol"},{"key":"R14-2-20250203","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.3800287","article-title":"Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.","volume":"18","author":"Yang","year":"2005","journal-title":"Mod Pathol"},{"key":"R15-2-20250203","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-9440(10)64262-9","article-title":"Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.","volume":"161","author":"Lee","year":"2002","journal-title":"Am J Pathol"},{"key":"R16-2-20250203","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.20944","article-title":"Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors.","volume":"115","author":"Tischoff","year":"2005","journal-title":"Int J Cancer"},{"key":"R17-2-20250203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2559.1998.00445.x","article-title":"Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma.","volume":"33","author":"Sugawara","year":"1998","journal-title":"Histopathology"},{"key":"R18-2-20250203","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3748\/wjg.14.2578","article-title":"Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines.","volume":"14","author":"Xu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R19-2-20250203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/13651820601156090","article-title":"Liver transplantation for non-hepatocellular carcinoma malignancy.","volume":"9","author":"Castaldo","year":"2007","journal-title":"HPB (Oxford)"},{"key":"R20-2-20250203","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver.","volume":"110","author":"Penn","year":"1991","journal-title":"Surgery"},{"key":"R21-2-20250203","first-page":"1","article-title":"Assessment of five-year experience with abdominal organ cluster transplantation.","volume":"180","author":"Alessiani","year":"1995","journal-title":"J Am Coll Surg"},{"key":"R22-2-20250203","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients.","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"R23-2-20250203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","article-title":"Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma.","volume":"239","author":"Robles","year":"2004","journal-title":"Ann Surg"},{"key":"R24-2-20250203","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.","volume":"7","author":"Shimoda","year":"2001","journal-title":"Liver Transpl"},{"key":"R25-2-20250203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13651820310019938","article-title":"Liver transplantation is not indicated for cholangiocarcinoma.","volume":"5","author":"Pinson","year":"2003","journal-title":"HPB (Oxford)"},{"key":"R26-2-20250203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/lv.2000.6143","article-title":"Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.","volume":"6","author":"De Vreede","year":"2000","journal-title":"Liver Transpl"},{"key":"R27-2-20250203","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma.","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"R28-2-20250203","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"R29-2-20250203","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","article-title":"Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.","volume":"82","author":"Heimbach","year":"2006","journal-title":"Transplantation"},{"key":"R30-2-20250203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","article-title":"Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period.","volume":"12","author":"Becker","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R31-2-20250203","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"issue":"pt 1","key":"R32-2-20250203","first-page":"297","article-title":"Vascular lesions following radiation.","volume":"23","author":"Fajardo","year":"1988","journal-title":"Pathol Annu"},{"key":"R33-2-20250203","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/lt.21107","article-title":"Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.","volume":"13","author":"Mantel","year":"2007","journal-title":"Liver Transpl"},{"key":"R34-2-20250203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.21287","article-title":"Long-term, tumor-free survival after radiotherapy combining hepatectomy-whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.","volume":"14","author":"Wu","year":"2008","journal-title":"Liver Transpl"},{"key":"R35-2-20250203","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00423-003-0383-5","article-title":"Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.","volume":"388","author":"Neuhaus","year":"2003","journal-title":"Langenbecks Arch Surg"},{"key":"R36-2-20250203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma.","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"key":"R37-2-20250203","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/01.tp.0000187106.29908.2b","article-title":"Extended indications in living-donor liver transplantation: bile duct cancer.","volume":"80","author":"Jonas","year":"2005","journal-title":"Transplantation"},{"key":"R38-2-20250203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2008.08.024","article-title":"Prognostic molecular markers in cholangiocarcinoma: a systematic review.","volume":"45","author":"Briggs","year":"2009","journal-title":"Eur J Cancer"},{"key":"R39-2-20250203","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s005340070039","article-title":"p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.","volume":"7","author":"Ahrendt","year":"2000","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R40-2-20250203","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.1840220313","article-title":"p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival.","volume":"22","author":"Diamantis","year":"1995","journal-title":"Hepatology"},{"key":"R41-2-20250203","first-page":"927","article-title":"Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.","volume":"47","author":"Havlik","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"R42-2-20250203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/ejso.1998.0645","article-title":"p53 expression as a prognostic determinant in resected distal bile duct carcinoma.","volume":"25","author":"Rijken","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"R43-2-20250203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1005412626515","article-title":"Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.","volume":"45","author":"Tannapfel","year":"2000","journal-title":"Dig Dis Sci"},{"key":"R44-2-20250203","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1245\/s10434-006-9260-0","article-title":"Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases.","volume":"14","author":"Cheng","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R45-2-20250203","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/hep.510300506","article-title":"Decreased p27 (Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.","volume":"30","author":"Hui","year":"1999","journal-title":"Hepatology"},{"key":"R46-2-20250203","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0168-8278(01)00079-4","article-title":"The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma.","volume":"35","author":"Sugimachi","year":"2001","journal-title":"J Hepatol"},{"key":"R47-2-20250203","first-page":"5","article-title":"Resectability and prognostic factors after resection of hilar cholangiocarcinoma.","volume":"53","author":"Abdel Wahab","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"R48-2-20250203","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjsurg.2004.01.007","article-title":"Outcomes after resection of cholangiocellular carcinoma.","volume":"187","author":"Huang","year":"2004","journal-title":"Am J Surg"},{"key":"R49-2-20250203","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1365-2168.2002.02268.x","article-title":"Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.","volume":"89","author":"Ohtsuka","year":"2002","journal-title":"Br J Surg"},{"issue":"suppl 1","key":"R50-2-20250203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000080731","article-title":"Epidemiology of neuroendocrine tumours.","volume":"80","author":"Taal","year":"2004","journal-title":"Neuroendocrinology"},{"key":"R51-2-20250203","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.1981.03310490014012","article-title":"Von Recklinghausens disease and gastrointestinal carcinoids.","volume":"245","author":"Johnson","year":"1981","journal-title":"JAMA"},{"key":"R52-2-20250203","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9440(10)65563-0","article-title":"Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.","volume":"153","author":"Lubensky","year":"1998","journal-title":"Am J Pathol"},{"key":"R53-2-20250203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/02841869309083898","article-title":"Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system.","volume":"32","author":"Chaudhry","year":"1993","journal-title":"Acta Oncol"},{"key":"R54-2-20250203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000478-199703000-00009","article-title":"Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids.","volume":"21","author":"Krishnamurthy","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R55-2-20250203","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.2910600514","article-title":"Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.","volume":"60","author":"Nilsson","year":"1995","journal-title":"Int J Cancer"},{"key":"R56-2-20250203","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/modpathol.3800427","article-title":"Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.","volume":"18","author":"Papouchado","year":"2005","journal-title":"Mod Pathol"},{"key":"R57-2-20250203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2559.1998.00321.x","article-title":"Expression of vascular endothelial growth factor in digestive neuroendocrine tumours.","volume":"32","author":"Terris","year":"1998","journal-title":"Histopathology"},{"key":"R58-2-20250203","first-page":"4573","article-title":"Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells.","volume":"60","author":"von Wichert","year":"2000","journal-title":"Cancer Res"},{"key":"R59-2-20250203","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/cncr.22554","article-title":"Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors.","volume":"109","author":"Zhang","year":"2007","journal-title":"Cancer"},{"key":"R60-2-20250203","first-page":"48","article-title":"Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.","volume":"111","author":"Soreide","year":"1992","journal-title":"Surgery"},{"key":"R61-2-20250203","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/lt.20702","article-title":"Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival.","volume":"12","author":"van Vilsteren","year":"2006","journal-title":"Liver Transpl"},{"key":"R62-2-20250203","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9610(99)80107-X","article-title":"Hepatic resection for metastatic neuroendocrine carcinomas.","volume":"169","author":"Que","year":"1995","journal-title":"Am J Surg"},{"key":"R63-2-20250203","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/msy.2001.117377","article-title":"Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors.","volume":"130","author":"Yao","year":"2001","journal-title":"Surgery"},{"key":"R64-2-20250203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjsurg.2003.04.007","article-title":"Management of neuroendocrine liver metastases.","volume":"187","author":"Sutcliffe","year":"2004","journal-title":"Am J Surg"},{"key":"R65-2-20250203","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00147-003-0605-3","article-title":"Liver transplantation for metastatic colon adenocarcinoma: report of a case with 10 years of follow-up without recurrence.","volume":"16","author":"Honore","year":"2003","journal-title":"Transpl Int"},{"key":"R66-2-20250203","first-page":"409","article-title":"Liver transplantation for liver metastases of colorectal cancer in Japanese.","volume":"102","author":"Urata","year":"2001","journal-title":"Nippon Geka Gakkai Zasshi"},{"key":"R67-2-20250203","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00007890-199811270-00007","article-title":"Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients.","volume":"66","author":"Lehnert","year":"1998","journal-title":"Transplantation"},{"key":"R68-2-20250203","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1749-6632.1994.tb17301.x","article-title":"Liver transplantation for hepatic metastases of neuroendocrine tumors.","volume":"733","author":"Bechstein","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"R69-2-20250203","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00007890-200202150-00012","article-title":"Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.","volume":"73","author":"Rosenau","year":"2002","journal-title":"Transplantation"},{"key":"R70-2-20250203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown.","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"issue":"pt 6","key":"R71-2-20250203","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1242\/jcs.000455","article-title":"Cadherin switching.","volume":"121","author":"Wheelock","year":"2008","journal-title":"J Cell Sci"},{"key":"R72-2-20250203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.gassur.2003.11.010","article-title":"Liver transplantation for neuroendocrine tumors.","volume":"8","author":"Florman","year":"2004","journal-title":"J Gastrointest Surg"},{"key":"R73-2-20250203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1196\/annals.1294.029","article-title":"Liver transplantation for treatment of metastatic neuroendocrine tumors.","volume":"1014","author":"Ahlman","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R74-2-20250203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/lt.21056","article-title":"Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors.","volume":"13","author":"Olausson","year":"2007","journal-title":"Liver Transpl"},{"key":"R75-2-20250203","first-page":"1973","article-title":"Liver transplantation for metastatic neuroendocrine tumors.","volume":"25","author":"Schweizer","year":"1993","journal-title":"Transplant Proc"},{"key":"R76-2-20250203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11605-007-0247-3","article-title":"Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005.","volume":"12","author":"Rodriguez","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R77-2-20250203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/modpathol.3800986","article-title":"Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver.","volume":"21","author":"Fujii","year":"2008","journal-title":"Mod Pathol"},{"key":"R78-2-20250203","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00000478-198510000-00001","article-title":"Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use.","volume":"9","author":"Dean","year":"1985","journal-title":"Am J Surg Pathol"},{"key":"R79-2-20250203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0168-8278(89)90168-2","article-title":"Epithelioid hemangioendothelioma of the liver following contact with vinyl chloride. Recurrence after orthotopic liver transplantation.","volume":"8","author":"Gelin","year":"1989","journal-title":"J Hepatol"},{"key":"R80-2-20250203","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2318::AID-CNCR8>3.0.CO;2-I","article-title":"Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor.","volume":"78","author":"Lauffer","year":"1996","journal-title":"Cancer"},{"key":"R81-2-20250203","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/SLA.0b013e31815c2a70","article-title":"The place of liver transplantation in the treatment of hepatic epithelioid hemangioendothelioma: report of the European liver transplant registry.","volume":"246","author":"Lerut","year":"2007","journal-title":"Ann Surg"},{"key":"R82-2-20250203","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.22225","article-title":"Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy.","volume":"107","author":"Mehrabi","year":"2006","journal-title":"Cancer"},{"key":"R83-2-20250203","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02307080","article-title":"Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma.","volume":"2","author":"Madariaga","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"R84-2-20250203","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/lt.500050612","article-title":"Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when?","volume":"5","author":"Ben-Haim","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R85-2-20250203","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1432-2277.2004.tb00429.x","article-title":"Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation.","volume":"17","author":"Lerut","year":"2004","journal-title":"Transpl Int"},{"key":"R86-2-20250203","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<562::AID-CNCR7>3.0.CO;2-T","article-title":"Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases.","volume":"85","author":"Makhlouf","year":"1999","journal-title":"Cancer"},{"key":"R87-2-20250203","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/01.tp.0000186904.15029.4a","article-title":"Surgical treatment of primary hepatic epithelioid hemangioendothelioma.","volume":"80","author":"Mehrabi","year":"2005","journal-title":"Transplantation"},{"key":"R88-2-20250203","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jso.21132","article-title":"Hepatic epithelioid hemangioendothelioma: long-term results of surgical management.","volume":"98","author":"Mosoia","year":"2008","journal-title":"J Surg Oncol"},{"key":"R89-2-20250203","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ejso.2007.01.021","article-title":"Orthotopic liver transplantation for epithelioid haemangioendothelioma.","volume":"33","author":"Zhang","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"R90-2-20250203","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.2910420408","article-title":"The international incidence of childhood cancer.","volume":"42","author":"Parkin","year":"1988","journal-title":"Int J Cancer"},{"key":"R91-2-20250203","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/spsu.2000.18844","article-title":"Liver tumors.","volume":"9","author":"Stringer","year":"2000","journal-title":"Semin Pediatr Surg"},{"key":"R93-2-20250203","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2559.1997.2750870.x","article-title":"Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6.","volume":"31","author":"Ruck","year":"1997","journal-title":"Histopathology"},{"key":"R94-2-20250203","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1038\/sj.onc.1207782","article-title":"Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.","volume":"23","author":"Yamada","year":"2004","journal-title":"Oncogene"},{"key":"R95-2-20250203","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ejca.2005.02.035","article-title":"The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis.","volume":"41","author":"Zimmermann","year":"2005","journal-title":"Eur J Cancer"},{"key":"R96-2-20250203","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-3468(99)90164-1","article-title":"Orthotopic liver transplantation for unresectable hepatoblastoma: a single centers experience.","volume":"34","author":"Al-Qabandi","year":"1999","journal-title":"J Pediatr Surg"},{"key":"R97-2-20250203","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1399-3046.2005.00354.x","article-title":"Liver transplantation for hepatoblastoma: indications and contraindications in the modern era.","volume":"9","author":"Otte","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R98-2-20250203","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/lt.21654","article-title":"Liver tumors: pediatric population.","volume":"14","author":"Finegold","year":"2008","journal-title":"Liver Transpl"},{"key":"R99-2-20250203","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","article-title":"Pretreatment prognostic factors for children with hepatoblastomaresults from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.","volume":"36","author":"Brown","year":"2000","journal-title":"Eur J Cancer"},{"key":"R100-2-20250203","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1053\/jpsu.2001.22953","article-title":"Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.","volume":"36","author":"Carceller","year":"2001","journal-title":"J Pediatr Surg"},{"key":"R101-2-20250203","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2005.02.004","article-title":"Guidelines for surgical treatment of hepatoblastoma in the modern erarecommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL).","volume":"41","author":"Czauderna","year":"2005","journal-title":"Eur J Cancer"},{"key":"R102-2-20250203","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cncr.10282","article-title":"Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.","volume":"94","author":"Schnater","year":"2002","journal-title":"Cancer"},{"key":"R103-2-20250203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mpo.10172","article-title":"Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice.","volume":"39","author":"Finegold","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"R104-2-20250203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00000658-199102000-00004","article-title":"Liver transplantation for hepatoblastoma. The American experience.","volume":"213","author":"Koneru","year":"1991","journal-title":"Ann Surg"},{"key":"R105-2-20250203","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/lt.21586","article-title":"Liver transplantation for hepatoblastoma.","volume":"14","author":"Faraj","year":"2008","journal-title":"Liver Transpl"},{"key":"R106-2-20250203","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience.","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R107-2-20250203","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jpedsurg.2005.10.091","article-title":"Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.","volume":"41","author":"Austin","year":"2006","journal-title":"J Pediatr Surg"},{"key":"R108-2-20250203","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jpedsurg.2007.08.030","article-title":"Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.","volume":"42","author":"Meyers","year":"2007","journal-title":"J Pediatr Surg"},{"key":"R109-2-20250203","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1097-0142(20001015)89:8<1845::AID-CNCR27>3.0.CO;2-D","article-title":"Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors.","volume":"89","author":"Perilongo","year":"2000","journal-title":"Cancer"},{"key":"R110-2-20250203","first-page":"1886","article-title":"Fibrolamellar hepatocellular carcinoma: report of a case.","volume":"50","author":"Kitabayashi","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R111-2-20250203","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1038\/ajg.2009.440","article-title":"Fibrolamellar hepatocellular carcinoma.","volume":"104","author":"Liu","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R112-2-20250203","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.21703","article-title":"Outcome of patients with fibrolamellar hepatocellular carcinoma.","volume":"106","author":"Stipa","year":"2006","journal-title":"Cancer"},{"key":"R113-2-20250203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/bjs.4763","article-title":"Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis.","volume":"92","author":"Lang","year":"2005","journal-title":"Br J Surg"},{"key":"R114-2-20250203","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.20704","article-title":"AASLD practice guidelines: evaluation of the patient for liver transplantation.","volume":"41","author":"Murray","year":"2005","journal-title":"Hepatology"},{"key":"R115-2-20250203","first-page":"145","article-title":"Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver.","volume":"162","author":"Starzl","year":"1986","journal-title":"Surg Gynecol Obstet"},{"key":"R116-2-20250203","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hep.510260412","article-title":"Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.","volume":"26","author":"Pinna","year":"1997","journal-title":"Hepatology"},{"key":"R117-2-20250203","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1634\/theoncologist.2-3-164","article-title":"Indications and role of liver transplantation for malignant tumors.","volume":"2","author":"Pichlmayr","year":"1997","journal-title":"Oncologist"},{"issue":"suppl 1","key":"R118-2-20250203","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1111\/j.1432-2277.2000.tb02071.x","article-title":"Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma.","volume":"13","author":"El-Gazzaz","year":"2000","journal-title":"Transpl Int"},{"key":"R119-2-20250203","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.transproceed.2008.09.050","article-title":"Preemptive live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report.","volume":"40","author":"Fouzas","year":"2008","journal-title":"Transplant Proc"},{"key":"R120-2-20250203","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/lt.20132","article-title":"Living donor liver transplant for fibrolamellar hepatocellular carcinoma using a deceased donor graft to reconstruct inferior vena cava.","volume":"10","author":"Slater","year":"2004","journal-title":"Liver Transpl"},{"key":"R121-2-20250203","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1600-6143.2005.01179.x","article-title":"Liver transplantation for primary or metastatic sarcoma to the liver.","volume":"6","author":"Husted","year":"2006","journal-title":"Am J Transplant"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22106","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.22106","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201008000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:01:00Z","timestamp":1738609260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201008000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":120,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.22106","relation":{},"ISSN":["1527-6465"],"issn-type":[{"type":"print","value":"1527-6465"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}